Cargando…

Correction to: A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases

Detalles Bibliográficos
Autores principales:	Katsigianni, Eleni Ioanna, Petrou, Panagiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724343/ https://www.ncbi.nlm.nih.gov/pubmed/36474287 http://dx.doi.org/10.1186/s12962-022-00392-x

Ejemplares similares

A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases
por: Katsigianni, Eleni Ioanna, et al.
Publicado: (2022)

Enzyme replacement therapy for lysosomal storage disorders in India
por: Muranjan, Mamta
Publicado: (2014)

Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases
por: Nathan, David G, et al.
Publicado: (2009)

Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders
por: Hendriksz, Christian J., et al.
Publicado: (2018)

Role of the Lactide:Glycolide Ratio in PLGA Nanoparticle Stability and Release under Lysosomal Conditions for Enzyme Replacement Therapy of Lysosomal Storage Disorders
por: del Moral, Maria, et al.
Publicado: (2023)

Correction: Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
Publicado: (2014)

Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies
por: Vijay, Suresh, et al.
Publicado: (2021)

Low-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage Disease
por: Alliegro, Marialuisa, et al.
Publicado: (2016)

Toward Engineering the Mannose 6-Phosphate Elaboration Pathway in Plants for Enzyme Replacement Therapy of Lysosomal Storage Disorders
por: Zeng, Ying, et al.
Publicado: (2019)

Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
Publicado: (2014)

The economics of TAVI: A systematic review
por: Petrou, Panagiotis
Publicado: (2023)

Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
por: Husereau, Don, et al.
Publicado: (2022)

Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review
por: Bashir, Aamir, et al.
Publicado: (2021)

The use of port-a-caths in adult patients with Lysosomal Storage Disorders receiving Enzyme Replacement Therapy-one centre experience
por: McLoughlin, Mairead, et al.
Publicado: (2017)

Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2022)

Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
por: Paracha, Noman, et al.
Publicado: (2022)

Correction: A systematic literature review of economic evaluation studies of interventions impacting antimicrobial resistance
por: Painter, Chris, et al.
Publicado: (2023)

Comparison between Nanoparticle Encapsulation and Surface Loading for Lysosomal Enzyme Replacement Therapy
por: Muntimadugu, Eameema, et al.
Publicado: (2022)

Author Correction: Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
por: Moretti, Federico A., et al.
Publicado: (2021)

Engineering of GlcNAc-1-Phosphotransferase for Production of Highly Phosphorylated Lysosomal Enzymes for Enzyme Replacement Therapy
por: Liu, Lin, et al.
Publicado: (2017)

Correction to: Economic evaluation of advanced practice physiotherapy models of care: a systematic review with meta-analyses
por: Lafrance, Simon, et al.
Publicado: (2022)

Mannose-6-phosphate glycan for lysosomal targeting: various applications from enzyme replacement therapy to lysosome-targeting chimeras
por: Seo, Jinho, et al.
Publicado: (2022)

Lysosomes and Lysosomal Storage Diseases
por: Noebels, Jeffrey L.
Publicado: (1981)

Coutinho et al. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders. Int. J. Mol. Sci. 2016, 17, 1065
por: Coutinho, Maria Francisca, et al.
Publicado: (2017)

The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease
por: Monaco, Antonio, et al.
Publicado: (2022)

Health economic evaluation of gene replacement therapies: methodological issues and recommendations
por: Aballéa, Samuel, et al.
Publicado: (2020)

Correction: Economic burden of chronic migraine in OECD countries: a systematic review
por: Eltrafi, Alyaa, et al.
Publicado: (2023)

Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results
por: Diaz, George A., et al.
Publicado: (2023)

Correction: Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches
por: Ali, Haivin Aziz, et al.
Publicado: (2019)

RTB Lectin: a novel receptor-independent delivery system for lysosomal enzyme replacement therapies
por: Acosta, Walter, et al.
Publicado: (2015)

Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapy
por: Sugiman-Marangos, S. N., et al.
Publicado: (2020)

Correction: Keratinocyte differentiation promotes ER stress-dependent lysosome biogenesis
por: Mahanty, Sarmistha, et al.
Publicado: (2019)

Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
Publicado: (2020)

Correction to: Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications
por: Okafor, Charles Ebuka
Publicado: (2021)

Correction: Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Publicado: (2018)

Correction to: DeSP: a systematic DNA storage error simulation pipeline
por: Yuan, Lekang, et al.
Publicado: (2022)

Correction to: Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
por: Neff, Guy, et al.
Publicado: (2018)

Crossing the gates of Babylon: Brain-penetrating enzyme replacement for lysosomal disorders
por: Baldo, Guilherme
Publicado: (2023)

Correction: The Challenges of Mitochondrial Replacement
Publicado: (2014)

Systematic review of economic evaluations of varicella vaccination programmes
por: Anderson, Robert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8udvfvtvvh7q8ugc366i5eb1tf